Chattopadhyay, N., Berger, A. J., Koenig, E., Bannerman, B., Garnsey, J., Bernard, H., . . . Amidon, B. KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationChattopadhyay, Nibedita, et al. KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism. Public Library of Science (PLoS).
MLA (9th ed.) CitationChattopadhyay, Nibedita, et al. KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism. Public Library of Science (PLoS).